Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ºñ°æ±¸ Åõ¿©ÇÑ Streptococcus mutans ±Õü ¹× Glucosyltransferase¿¡ ´ëÇÑ ¸¶¿ì½ºÀÇ ¸é¿ªÇ×ü¹ÝÀÀ

ANTIBODY PRODUCTION BY PARENTERAL ADMINISTRATION OF STREPTOCOCCUS MUTANS AND GLUCOSYLTRANSFERASE IN MICE

´ëÇѼҾÆÄ¡°úÇÐȸÁö 2003³â 30±Ç 1È£ p.61 ~ 68
¾ç±ÔÈ£, Á¤¹Ì, Á¤Áø, Àå¹Ì¿µ, ¿ÀÁ¾¼®, ³ªÈñ»ï, °­ÀÎö,
¼Ò¼Ó »ó¼¼Á¤º¸
¾ç±ÔÈ£ (  ) - Àü³²´ëÇб³ Ä¡°ú´ëÇÐ ¼Ò¾ÆÄ¡°úÇб³½Ç
Á¤¹Ì (  ) - Àü³²´ëÇб³ Ä¡°ú´ëÇÐ ¼Ò¾ÆÄ¡°úÇб³½Ç
Á¤Áø (  ) - ºÎ»ê´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­¹Ì»ý¹°Çб³½Ç
Àå¹Ì¿µ ( Chang Mee-Young ) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¹Ì»ý¹°Çб³½Ç
¿ÀÁ¾¼® (  ) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¹Ì»ý¹°Çб³½Ç
³ªÈñ»ï (  ) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¹Ì»ý¹°Çб³½Ç
°­ÀÎö (  ) - Àü³²´ëÇб³ Ä¡ÀÇÇבּ¸¼Ò, ±¸°­¹Ì»ý¹°Çб³½Ç

Abstract

Ä¡¾Æ¿ì½ÄÁõÀ» ¿¹¹æÇϱâ À§ÇÑ ¹é½Å¿¬±¸¸¦ À§ÇÏ¿© ÁÖ¿øÀαÕÀÎ Sterptococcus mutans ±ÕüÇ׿ø°ú ÀÌ ±Õ¿¡¼­ ºÐ¸®ÇÑ glucosyltransferase(GTF)¸¦ Ç׿øÀ¸·Î ÇÏ°í ÀÌ¿¡ ¸é¿ªÁ¶Àý±â´ÉÀÌ ÀÖ´Â retinoic acid (RA)¸¦ ÷°¡ÇÏ¿© Åõ¿©°æ·Î¿Í ¹é½ÅÁ¶¼ºÀÌ À̵é Ç׿ø¿¡ ´ëÇÑ ¸é¿ª¹ÝÀÀ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ½ÇÇèÇÏ¿´´Ù.
±ÕüÇ׿ø(Ingbritt strain)À» ¸¶¿ì½ºÀÇ ÇÇÇÏ¿¡ Complete Freund¢¥s Adjuvant¿Í ÇÔ²² Åõ¿©ÇÏ¿© »ý»êµÇ´Â Ç÷û³» ÀÀÁýÇ×ü°¡´Â serotype e (LM-7)¿Í´Â °­ÇÑ ±³Â÷¹ÝÀÀÀ» º¸¿´À¸³ª serotype f (OMZ-175)¿Í´Â °ÅÀÇ ±³Â÷¹ÝÀÀÀ» ÀÏÀ¸Å°Áö ¾Ê¾Ò´Ù. ¸é¿ªÇ÷û³» Ç×-GTF ¹× Ç×-Ag ¥°/¥± Ç×üÁß Ç×-GTF IgA´Â ÇÇÇÏ·Î Åõ¿©½Ã ÀüÇô °ËÃâµÇÁö ¾Ê¾ÒÀ¸³ª ÀÌ¿¡ RA¸¦ ÷°¡ÇÏ¸é ´Ù·®ÀÇ Ç×ü »ý»êÀ» °üÂûÇÏ¿´°í ±× Á¤µµ´Â °æ±¸Åõ¿©½ÃÀÇ »ý»ê·®À» ´É°¡ÇÏ¿´´Ù. GTF¸¦ alum°ú ÇÔ²² Åõ¿©ÇÏ¿© »ý»êµÇ´Â Ç÷û³» Ç×-GTFÇ×üÁß IgMÀº ÇÇÇÏ·Î Åõ¿©½Ã »ó´ç·®ÀÌ °ËÃâµÇ¾ú°í RA¸¦ ÷°¡ÇÏ¸é ±× »ý»êÀÌ Áõ°¡µÇ¾úÀ¸¸ç °æ±¸·Î Åõ¿©½Ã ´ëÁ¶±º¿¡ ºñÇÏ¿© ¾à°£ Áõ°¡¸¦ º¸¿´À¸³ª ÇÇÇÏÅõ¿©½ÃÀÇ ±×°Í¿¡´Â ¹ÌÄ¡Áö ¸øÇÏ¿´´Ù. GTF-ƯÀÌ IgG´Â °æ±¸Åõ¿©½Ã´Â ÀüÇô °ËÃâµÇÁö ¾Æ´ÏÇÏ¿´°í, ÇÇÇÏÅõ¿©½Ã¿¡¸¸ ÇöÀúÇÑ Áõ°¡¸¦ º¸¿´À¸¸ç, RA÷°¡´Â ÀÌ¿¡ ¿µÇâÀ» ¹ÌÄ¡Áö ¸øÇÏ¿´´Ù. Ç×-GTF IgA´Â ÇÇÇÏ·Î Åõ¿©½Ã ÀüÇô °ËÃâµÇÁö ¾Æ´ÏÇÏ¿´À¸³ª ÀÌ¿¡ RA¸¦ ÷°¡Çϸé Áõ°¡µÈ Ç×ü»ý»êÀ» °üÂûÇÏ¿´°í ±× Á¤µµ´Â °æ±¸Åõ¿©½ÃÀÇ »ý»ê·®À» ´É°¡ÇÏ¿´´Ù.
ÀÌ»óÀÇ ½ÇÇ輺ÀûÀº GTF¿¡ ´ëÇÑ Ç×ü»ý»êÀº Åõ¿©°æ·Î¿Í Ç׿øÀÇ Á¾·ù¿¡ µû¶ó ´Ù¾çÇÑ ¹ÝÀÀÀ» ³ªÅ¸³»¸ç RA´Â À̸¦ ¹é½Å¿¡ ÷°¡Çϸé ÇÇÇÏ°æ·Î¸¦ ÀÌ¿ëÇÏ¿© ¸é¿ªÇÏ´õ¶óµµ °æ±¸Åõ¿©¿Í À¯»çÇÑ IgA-¸Å°³ ¸é¿ª¹ÝÀÀÀ¸·Î Á¶Àý½Ãų ¼ö ÀÖ´Â °¡´É¼ºÀ» ³ªÅ¸³»¾ú´Ù.

Streptococcus mutans is known to be a major causative organism of human dental caries. The development of a vaccine against dental caries involves identification of appropriate antigens of mutans streptococci against which protective immune responses can be mounted, and the selection of a method of immunization that will generate sustained levels of protective antibodies. Antigens receiving most attention include streptococcal surface proteins that are involved in attachment to tooth surfaces and glucosyltransferases (GTF) that synthesize adhesive glucans from sucrose. The induction of antibody responses to orally administered antigens is often difficult due to digestive destruction of antigens and immune tolerance. Here we report the induction of antibody responses to an anti-caries vaccine containing retinoic acid (RA). Subcutaneous immunization with formalin-fixed bacteria or GTF supplemented with RA induced higher serum IgM and IgA responses to GTF compaired to oral adminstration. Antisera induced by Ingbritt strain showed partial cross-reaction with LM-7 strain, but not with OMZ175. These results suggest that subcutaneous immunization with GTF combined with an immunomodulator, RA, may be applied to anti-caries vaccine.

Å°¿öµå

Streptococcus mutans;Glucosyltransferase(GTF);Retinoic acid;IgA

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI